Structural Formula (7db112de 473a 4407 Bc1c 35d0ab748700 01)
Cymbalta
Product Images NDC 21695-657
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cymbalta (NDC 21695-657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (7db112de 473a 4407 Bc1c 35d0ab748700 02)
Figure 2 (7db112de 473a 4407 Bc1c 35d0ab748700 03)
Figure 3 (7db112de 473a 4407 Bc1c 35d0ab748700 04)
Figure 4 (7db112de 473a 4407 Bc1c 35d0ab748700 05)
Figure 5 (7db112de 473a 4407 Bc1c 35d0ab748700 06)
The text represents a graph showing the percentage of patients improved in relation to the placebo and CYM60/120 mg once daily. The horizontal axis shows the percentage of improvement in pain from baseline, while the vertical axis represents the percentage of patients improved. The graph suggests that a higher percentage of patients experienced improvement in pain when treated with CYM60/120 mg once daily compared to the placebo.*
Figure 6 (7db112de 473a 4407 Bc1c 35d0ab748700 07)
This is a chart displaying the percentage of patients improved from a baseline in pain with a placebo and CYMB0 mg taken once daily. The chart shows a 100% improvement with the placebo and an 80% improvement with CYMB0 mg. The x-axis of the chart displays values ranging from 210 to 250, while the y-axis displays values ranging from 60 to 100.*
Figure 7 (7db112de 473a 4407 Bc1c 35d0ab748700 08)
The given text represents a graph showing the percentage of patients improvement in pain from baseline with the help of two medications- Placebo and CYMB0/120 mg taken once daily. The percentage on the y-axis spans from 0 to 100 and percentage of patients improved by each medication is plotted at the corresponding position. The percentage value of patients improvement by placebo is not available from the text.*
Cymbalta 20mg (7db112de 473a 4407 Bc1c 35d0ab748700 09)
This is a description of Cymbalta 20mg capsules containing Duloxetine hydrochloride, manufactured by Eli Lilly and Company, Indianapolis. The capsules are available in an opaque green body and cap, and are imprinted with "20 mg" on the body and "LILLY 3235" on the cap. Each capsule contains 22.4mg of Duloxetine hydrochloride, equivalent to 20mg of Duloxetine. The product ID is RC065760 and it can only be distributed upon prescription by a doctor. The medication must be kept at controlled room temperature and out of reach of children.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
